The role of government and regulation in cancer prevention

The Lancet Oncology

Volumn 18, Issue 8, 2017, Pages e483-e493

  Brawley, Otis W ^a,b  

^a AMERICAN CANCER SOCIETY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; HEPATITIS B VACCINE; WART VIRUS VACCINE;

AIR POLLUTION; ALCOHOL CONSUMPTION; BODY WEIGHT; CANCER PREVENTION; CANCER SCREENING; COLON CANCER; DISEASE SURVEILLANCE; ENVIRONMENTAL HEALTH; EXPOSURE; GOVERNMENT; GOVERNMENT REGULATION; HEALTH BEHAVIOR; HEALTH EDUCATION; HEALTH PROGRAM; HEALTH PROMOTION; HEPATITIS B; HUMAN; OBESITY; PAPILLOMAVIRUS INFECTION; PHYSICAL ACTIVITY; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REVIEW; SMOKING CESSATION; TOBACCO USE; UTERINE CERVIX CANCER; VACCINATION; DRINKING BEHAVIOR; EARLY CANCER DIAGNOSIS; ENVIRONMENTAL EXPOSURE; EXERCISE; HEALTHY DIET; LEGISLATION AND JURISPRUDENCE; NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; PREVENTION AND CONTROL; SMOKING; TOBACCO;

ALCOHOL DRINKING; EARLY DETECTION OF CANCER; ENVIRONMENTAL EXPOSURE; EXERCISE; GOVERNMENT; HEALTH EDUCATION; HEALTHY DIET; HEPATITIS B; HUMANS; IMMUNIZATION PROGRAMS; NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; SMOKING; TOBACCO PRODUCTS; TOBACCO USE CESSATION;

EID: 85029724162     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(17)30374-1     Document Type: Review

References (90)

1. Bray, F, Jemal, A, Grey, N, Ferlay, J, Forman, D, Global cancer transitions according to the Human Development Index (2008–2030): a population-based study. Lancet Oncol 13 (2012), 790–801.
2. Thun, MJ, DeLancey, JO, Center, MM, Jemal, A, Ward, EM, The global burden of cancer: priorities for prevention. Carcinogenesis 31 (2010), 100–110.
3. Colditz, GA, Wolin, KY, Gehlert, S, Applying what we know to accelerate cancer prevention. Sci Transl Med, 4, 2012, 127rv4.
4. McCullough, ML, Patel, AV, Kushi, LH, et al. Following cancer prevention guidelines reduces risk of cancer, cardiovascular disease, and all-cause mortality. Cancer Epidemiol Biomarkers Prev 20 (2011), 1089–1097.
5. Oza, S, Thun, MJ, Henley, SJ, Lopez, AD, Ezzati, M, How many deaths are attributable to smoking in the United States? Comparison of methods for estimating smoking-attributable mortality when smoking prevalence changes. Prev Med 52 (2011), 428–433.
6. Campbell, PT, Patel, AV, Newton, CC, Jacobs, EJ, Gapstur, SM, Associations of recreational physical activity and leisure time spent sitting with colorectal cancer survival. J Clin Oncol 31 (2013), 876–885.
7. Lauby-Secretan, B, Scoccianti, C, Loomis, D, et al. Body fatness and cancer—viewpoint of the IARC working group. N Engl J Med 375 (2016), 794–798.
8. Fontham, ET, Infectious diseases and global cancer control. CA Cancer J Clin 59 (2009), 5–7.
9. Hammond, EC, Horn, D, The relationship between human smoking habits and death rates: a follow-up study of 187 766 men. J Am Med Assoc 155 (1954), 1316–1328.
10. Doll, R, Hill, AB, Lung cancer and other causes of death in relation to smoking; a second report on the mortality of British doctors. Br Med J 2 (1956), 1071–1081.
11. Mazurek, JM, Syamlal, G, King, BA, Castellan, RM, Smokeless tobacco use among working adults—United States, 2005 and 2010. MMWR Morb Mortal Wkly Rep 63 (2014), 477–482.
12. Freedman, ND, Invited commentary: smokeless tobacco—an important contributor to cancer, but more work is needed. Am J Epidemiol, 2016 published online Oct 15. DOI:10.1093/aje/kww076.
13. Levy, DT, Mays, D, Boyle, RG, Tam, J, Chaloupka, FJ, The effect of tobacco control policies on US smokeless tobacco use: a structured review. Nicotine Tob Res, 2016 published online Oct 25. DOI:10.1093/ntr/ntw291.
14. Sasco, AJ, Secretan, MB, Straif, K, Tobacco smoking and cancer: a brief review of recent epidemiological evidence. Lung Cancer 45:suppl 2 (2004), S3–S9.
15. US Department of Health and Human Services. The health consequences of smoking—50 years of progress: a report of the Surgeon General, 2014, US Centers for Disease Control and Prevention, Atlanta, GA.
16. US Centers for Disease Control and Prevention. State-specific prevalence of cigarette smoking and smokeless tobacco use among adults—United States, 2009. MMWR Morb Mortal Wkly Rep 59 (2010), 1400–1406.
17. Kostova, D, Andes, L, Erguder, T, et al. Cigarette prices and smoking prevalence after a tobacco tax increase—Turkey, 2008 and 2012. MMWR Morb Mortal Wkly Rep 63 (2014), 457–461.
18. Pearson, AL, Cleghorn, CL, van der Deen, FS, et al. Tobacco retail outlet restrictions: health and cost impacts from multistate life-table modelling in a national population. Tob Control, 2016 published online Sept 22. DOI:10.1136/tobaccocontrol-2015-052846.
19. Community Preevntive Services Task Force. Reducing tobacco use and secondhand smoke exposure. https://www.thecommunityguide.org/sites/default/files/assets/Tobacco-Increasing-Unit-Price.pdf (accessed July 5, 2017).
20. Jamal, A, Homa, DM, O'Connor, E, et al. Current cigarette smoking among adults—United States, 2005–2014. MMWR Morb Mortal Wkly Rep 64 (2015), 1233–1240.
21. Hu, Y, van Lenthe, FJ, Platt, S, et al. The impact of tobacco control policies on smoking among socioeconomic groups in nine European countries, 1990–2007. Nicotine Tob Res, 2016 published online Aug 16. DOI:10.1093/ntr/ntw210.
22. Kuipers, MA, Brandhof, SD, Monshouwer, K, Stronks, K, Kunst, AE, Impact of laws restricting the sale of tobacco to minors on adolescent smoking and perceived obtainability of cigarettes: an intervention-control pre-post study of 19 European Union countries. Addiction 112 (2016), 320–329.
23. Eriksen, M, Chaloupka, F, The economic impact of clean indoor air laws. CA Cancer J Clin 57 (2007), 367–378.
24. Homa, DM, Neff, LJ, King, BA, et al. Vital signs: nonsmokers' exposure to secondhand smoke—United States, 1999–2008. MMWR Morb Mortal Wkly Rep 59 (2010), 1141–1146.
25. Ward, M, Currie, LM, Kabir, Z, Clancy, L, The efficacy of different models of smoke-free laws in reducing exposure to second-hand smoke: a multi-country comparison. Health Policy 110 (2013), 207–213.
26. Russell, A, Wainwright, M, Mamudu, H, A chilling example? Uruguay, Philip Morris International, and WHO's Framework Convention on Tobacco Control. Med Anthropol Q 29 (2015), 256–277.
27. Messer, K, Pierce, JP, Zhu, SH, et al. The California Tobacco Control Program's effect on adult smokers: (1) smoking cessation. Tob Control 16 (2007), 85–90.
28. Wakefield, M, Chaloupka, F, Effectiveness of comprehensive tobacco control programmes in reducing teenage smoking in the USA. Tob Control 9 (2000), 177–186.
29. Grimshaw, GM, Stanton, A, Tobacco cessation interventions for young people. Cochrane Database Syst Rev, 4, 2006 CD003289.
30. Graham, AL, Carpenter, KM, Cha, S, et al. Systematic review and meta-analysis of internet interventions for smoking cessation among adults. Subst Abuse Rehabil 7 (2016), 55–69.
31. Lemaire, RH, Bailey, L, Leischow, SJ, Meeting the tobacco cessation coverage requirement of the Patient Protection and Affordable Care Act: state smoking cessation quitlines and cost sharing. Am J Public Health 105:suppl 5 (2015), S699–S705.
32. Schmidt, AM, Ranney, LM, Pepper, JK, Goldstein, AO, Source credibility in tobacco control messaging. Tob Regul Sci 2 (2016), 31–37.
33. Brawley, OW, Glynn, TJ, Khuri, FR, Wender, RC, Seffrin, JR, The first Surgeon General's report on smoking and health: the 50th anniversary. CA Cancer J Clin 64 (2014), 5–8.
34. US Food and Drug Administration. Required warnings for cigarette packages and advertisements. Final rule. Fed Regist 76 (2011), 36628–36777.
35. Hogg, SL, Hill, SE, Collin, J, State-ownership of tobacco industry: a ‘fundamental conflict of interest’ or a ‘tremendous opportunity’ for tobacco control?. Tob Control 25 (2016), 367–372.
36. Glynn, T, Seffrin, JR, Brawley, OW, Grey, N, Ross, H, The globalization of tobacco use: 21 challenges for the 21st century. CA Cancer J Clin 60 (2010), 50–61.
37. Jayawardhana, J, Bradford, WD, Jones, W, Nietert, PJ, Silvestri, G, Master Settlement Agreement (MSA) spending and tobacco control efforts. PLoS One, 9, 2014, e114706.
38. Taylor, J, Taylor, A, Lewis, S, et al. A qualitative evaluation of a novel intervention using insight into tobacco industry tactics to prevent the uptake of smoking in school-aged children. BMC Public Health, 16, 2016, 539.
39. Perl, R, Murukutla, N, Occleston, J, et al. Responses to antismoking radio and television advertisements among adult smokers and non-smokers across Africa: message-testing results from Senegal, Nigeria and Kenya. Tob Control 24 (2015), 601–608.
40. Burki, TK, WHO Framework Convention on Tobacco Control conference. Lancet Oncol, 15, 2014, e588.
41. Framework Convention Alliance. Parties to the WHO FCTC (ratifications and accessions). http://www.fctc.org/about-fca/tobacco-control-treaty/latest-ratifications/parties-ratifications-accessions (accessed May 2, 2017).
42. Berteletti, F, King, J, Burch, J, Toma Friedlaender, A, Campaign for a revised tobacco products directive in the European Union: lessons learnt. Tob Control, 2016 DOI:10.1136/tobaccocontrol-2016-053078.
43. US Food and Drug Administration. Regulations restricting the sale and distribution of cigarettes and smokeless tobacco to protect children and adolescents. Final rule. Fed Reg 75 (2010), 13225–13232.
44. Cao, Y, Giovannucci, EL, Alcohol as a risk factor for cancer. Semin Oncol Nurs 32 (2016), 325–331.
45. Schutze, M, Boeing, H, Pischon, T, et al. Alcohol attributable burden of incidence of cancer in eight European countries based on results from prospective cohort study. BMJ, 342, 2011, d1584.
46. Hashibe, M, Brennan, P, Chuang, SC, et al. Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev 18 (2009), 541–550.
47. UK Department of Health. UK Chief Medical Officers' alcohol guidelines review. Summary of the proposed guidelines. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/489795/summary.pdf (accessed May 2, 2017).
48. IARD. Drinking guidelines: general population. http://www.iard.org/policy-tables/drinking-guidelines-general-population (accessed June 11, 2017).
49. Mitchell, AD, Casben, J, Trade law and alcohol regulation: what role for a global alcohol marketing code?. Addiction 112:suppl 1 (2016), 109–116.
50. Elder, RW, Lawrence, B, Ferguson, A, et al. The effectiveness of tax policy interventions for reducing excessive alcohol consumption and related harms. Am J Prev Med 38 (2010), 217–229.
51. Pettigrew, S, Biagioni, N, Daube, M, Stafford, J, Jones, SC, Chikritzhs, T, Reverse engineering a ‘responsible drinking’ campaign to assess strategic intent. Addiction 111 (2016), 1107–1113.
52. Fontham, ET, Thun, MJ, Ward, E, et al. American Cancer Society perspectives on environmental factors and cancer. CA Cancer J Clin 59 (2009), 343–351.
53. International Agency for Research on Cancer. Agents classified by the IARC monographs, volumes 1–118. http://monographs.iarc.fr/ENG/Classification (accessed May 2, 2017).
54. Chafe, ZA, Brauer, M, Klimont, Z, et al. Household cooking with solid fuels contributes to ambient PM2.5 air pollution and the burden of disease. Environ Health Perspect 122 (2014), 1314–1320.
55. Eheman, C, Henley, SJ, Ballard-Barbash, R, et al. Annual Report to the Nation on the status of cancer, 1975–2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer 118 (2012), 2338–2366.
56. The Lancet Oncology. Healthy choice should be the easy choice. Lancet Oncol, 13, 2012, 743.
57. Freedman, DS, Obesity—United States, 1988–2008. MMWR Surveill Summ 60:suppl (2011), 73–77.
58. Khan, LK, Sobush, K, Keener, D, et al. Recommended community strategies and measurements to prevent obesity in the United States. MMWR Recomm Rep 58 (2009), 1–26.
59. Tremblay, MS, Shephard, RJ, Brawley, LR, et al. Physical activity guidelines and guides for Canadians: facts and future. Can J Public Health 98:suppl 2 (2007), S218–S224.
60. Bauman, A, Cavill, N, Brawley, L, ParticipACTION: the future challenges for physical activity promotion in Canada. Int J Behav Nutr Phys Act, 6, 2009, 89.
61. Kushi, LH, Doyle, C, McCullough, M, et al. American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 62 (2012), 30–67.
62. Malik, VS, Willett, WC, Hu, FB, The revised nutrition facts label: a step forward and more room for improvement. JAMA 316 (2016), 583–584.
63. US Food and Drug Administration. Changes to the nutrition facts label. http://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/LabelingNutrition/ucm385663.htm (accessed May 2, 2017).
64. Lee, Y, Yoon, J, Chung, SJ, Lee, SK, Kim, H, Kim, S, Effect of TV food advertising restriction on food environment for children in South Korea. Health Promot Int, 2013 DOI:10.1093/heapro/dat078.
65. Kraak, VI, Story, M, Influence of food companies' brand mascots and entertainment companies' cartoon media characters on children's diet and health: a systematic review and research needs. Obes Rev 16 (2015), 107–126.
66. Sarlio-Lahteenkorva, S, Winkler, JT, Could a sugar tax help combat obesity?. BMJ, 351, 2015, h4047.
67. Colchero, MA, Guerrero-Lopez, CM, Molina, M, Rivera, JA, Beverages sales in Mexico before and after implementation of a sugar sweetened beverage tax. PLoS One, 11, 2016, e0163463.
68. Zapata-Diomedi, B, Herrera, AM, Veerman, JL, The effects of built environment attributes on physical activity-related health and health care costs outcomes in Australia. Health Place 42 (2016), 19–29.
69. Paul, P, Carlson, SA, Fulton, JE, Walking and the perception of neighborhood attributes among US adults—2012. J Phys Act Health 14 (2017), 36–44.
70. Islami, F, Liu, Y, Jemal, A, et al. Breastfeeding and breast cancer risk by receptor status—a systematic review and meta-analysis. Ann Oncol 26 (2015), 2398–2407.
71. The Cancer Atlas. The burden. http://canceratlas.cancer.org/the-burden/ (accessed May 2, 2017).
72. Braithwaite, D, Boffetta, P, Rebbeck, TR, Meyskens, F, Cancer prevention for global health: a report from the ASPO International Cancer Prevention Interest Group. Cancer Epidemiol Biomarkers Prev 21 (2012), 1606–1610.
73. European Centre for Disease Prevention and Control. Introduction of HPV vaccines in EU countries—an update, 2012, ECDC, Stockholm.
74. Krugman, S, Hepatitis virus vaccines: present status. Yale J Biol Med 55 (1982), 375–381.
75. Chien, YC1, Jan, CF, Kuo, HS, Chen, CJ, Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched. Epidemiol Rev 28 (2006), 126–135.
76. Chang, MH, Chen, CJ, Lai, MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 336 (1997), 1855–1859.
77. WHO. Hepatitis B (HepB3). Immunization coverage estimates by country. http://apps.who.int/gho/data/view.main.80300?lang=en (accessed May 2, 2017).
78. McNamara, M, Batur, P, Walsh, JM, Johnson, KM, HPV update: vaccination, screening, and associated disease. J Gen Intern Med 31 (2016), 1360–1366.
79. Loharikar, A, Dumolard, L, Chu, S, Hyde, T, Goodman, T, Mantel, C, Status of new vaccine introduction —worldwide, September 2016. MMWR Morb Mortal Wkly Rep 65 (2016), 1136–1140.
80. Larson, HJ, Wilson, R, Hanley, S, Parys, A, Paterson, P, Tracking the global spread of vaccine sentiments: the global response to Japan's suspension of its HPV vaccine recommendation. Hum Vaccin Immunother 10 (2014), 2543–2550.
81. de Bruijn, W, Ibanez, C, Frisk, P, et al. Introduction and utilization of high priced HCV medicines across Europe; implications for the future. Front Pharmacol, 7, 2016, 197.
82. Mozalevskis, A, Eramova, I, Safreed-Harmon, K, Lazarus, JV, Hepatitis B and C surveillance and screening programmes in the non-EU/EEA Member States of the WHO European Region: survey findings from 10 countries, 2012. Euro Surveill 22 (2016), 1–8.
83. Martin, EG, Norcott, AM, Khalid, H, O'Connell, DA, Implementing updated recommendations on hepatitis C virus screening: translating federal guidance into state practice. J Public Health Manag Pract, 2017 DOI:10.1097/PHH.0000000000000266.
84. Jorgensen, C, Carnes, CA, Downs, A, “Know More Hepatitis”: CDC's national education campaign to increase hepatitis C testing among people born between 1945 and 1965. Public Health Rep 131:suppl 2 (2016), 29–34.
85. Asaka, M, Elimination of gastric cancer from Japan. Nihon Rinsho 70 (2012), 1667–1672 (in Japanese).
86. Smith, RA, Andrews, KS, Brooks, D, et al. Cancer screening in the United States, 2017: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin 67 (2017), 100–121.
87. Vesco, KK, Whitlock, EP, Eder, M, et al. Screening for cervical cancer: a systematic evidence review for the U.S. Preventive Services Task Force. US Preventive Services Task Force Evidence Syntheses, 2011, Agency for Healthcare Research and Quality, Rockville.
88. Rabeneck, L, Lansdorp-Vogelaar, I, Assessment of a cancer screening program. Best Pract Res Clin Gastroenterol 29 (2015), 979–985.
89. Dickman, SL, Himmelstein, DU, McCormick, D, Woolhandler, S, Health and financial consequences of 24 states' decision to opt out of Medicaid expansion. Int J Health Serv 45 (2015), 133–142.
90. The Cancer Atlas. Cancer registries. http://canceratlas.cancer.org/taking-action/cancer-registries (accessed July 10, 2017).